Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
78 Cards in this Set
- Front
- Back
AP
|
-depend on Na+/K+ channels
-electrical along nerve |
|
NT
|
Chemical at nerve ending
|
|
Response=
|
Transmitter + Receptor
|
|
CNS acts on which 3 systems?
|
-Peripheral
-Autonomic -Somatic |
|
NT for sympathetic NS ?
|
Noradrenaline
|
|
Norad acts on
|
Alpha & Beta receptors
|
|
Parasympathetic NS uses
|
ACh as NT(pupil constriction and Increased salivation)
|
|
Ach acts on
|
Muscarinic receptors.
|
|
NT for somatic system?
|
ACh--> acts on Nicotinic receptors(MUSCLES)
|
|
Some drugs that affect PNS can have
|
Dramatic CNS effects
|
|
Receptors important for
|
Transmitter recognition & signal transduction.
|
|
Ion channels important for
|
AP propagation and NT release
|
|
Enzymes
|
Transmitter synthesis/inactivation
|
|
Transporters
|
Transmitter synthesis/inactivation.
|
|
Steps common in both CNS & PNS where drugs can act ?
|
-Synthesis,storage,release & inactivation of NT,activation of receptors on target tissue.
|
|
Cerebral cortex
|
-Abstract thought
-memory -Consciousness |
|
Mesencephalon
|
-Emotion
-Motivation -motor coordination,memory |
|
Cerebellum
|
-Mvt and posture
|
|
Brainstem
|
Reflex co-ordination of CV and respiratory systems
|
|
Spinal cord
|
afferent and efferent neural connection to periphery.
|
|
Peripheral NT
|
ACh & NORAD.
|
|
Monoamines NTs
|
Adrenaline,Dopamine,Serotonin
|
|
Amino acids NTs
|
GABA & glutamate
|
|
Peptides NT
|
Opioids
|
|
Small molecules NT
|
Nitric oxide
|
|
How are drugs that INCREASE Norad and Serotonin levels called?
|
Antidepressants
|
|
In the tx of Parkinson's disease,we use drugs that
|
Increase dopamine in basal ganglia(need to balance with Increased dopamine in other areas of brain-schizo/drug dependence)
|
|
In the tx of EPILEPSY,we use drugs that
|
Increase GABA activity in brain
|
|
Drugs that inhibit muscarinic ACh receptors
|
are use to treat some of the symptoms of Parkinson's/
|
|
Potential use of drugs that increase ACh levels in tx of
|
Alzheimer's disease.
|
|
Centrally acting drugs are generally assoc. with
|
numerous side effects.
|
|
Dopamine D2 receptor function in
|
Schizo.
|
|
Chemical signalling is not only important for communication of info between neurones but also for their
|
Survival
|
|
Neurotrophic factors
|
-maintain neuronal integrity/vital for nerve function
-loss of factors leads to nerve cell degeneration. |
|
Norad. pathway
|
Tyrosine-->L-DOPA-->Dopamine-->Norad.
|
|
What is the max. V1 enz. in the above pathway?
|
Tyrosine hydroxylase
|
|
Dopa carboxylase acts
|
On L-DOPA --> dopamine
|
|
Dopamine is taken up by
|
vesicles(previous steps in the pathway takes place in cytoplasm)
|
|
Where does the rn. involving dopamine takes place?
|
Inside vesicles--> dopamine Beta hydroxylase--> Noradrenaline
|
|
Tyrosine hydroxylase acts on
|
tyrosine--> L-DOPA
|
|
Amphetamine displaces
|
NA from vesicles(wakefulness but psychoses)
|
|
L-DOPA
|
for Parkinson's pts
|
|
"Reserpin"
|
Lost libido /erectile dysfunction.
|
|
Norad. inactivation
|
Uptake followed by metabolism
|
|
2 types of uptake of NA occurs:-
|
-Neuronal uptake
-Extra neuronal uptake |
|
2 enz. involved in metabolism of NA :-
|
-COMT
-MAO |
|
Drug interfering with neuronal uptake of NA
|
Cocaine
|
|
Drug interfering with metabolism of NA
|
Moclobemide
|
|
Both drugs above can affect
|
Mood.
|
|
NA affect
|
-Mood
-BP |
|
ACh affect
|
-Memory
-Learning -Motor function |
|
Depression assoc. with
|
Falls in Norad.,Dopamine,Serotonin in brain.
|
|
Inhibition of uptake
|
Elevates mood.
|
|
Cocaine blocks
|
Serotonin & dopamine uptake
|
|
Dopamine assoc. with
|
Dependence and psychoses.
|
|
SSRIs
|
Selective Serotonin Uptake Inhibitors
|
|
SSRIs
|
Effective Antidepressants.
|
|
Serotonin causes
|
Psychoses + hallucinations.
|
|
Monoamine oxidase inhibition
|
Elevates mood.
|
|
Monoamine oxidase A
|
Norad. is preferred susbtrate
|
|
Monoamine oxidase A INHIBITORS used for
|
depression
|
|
Monoamine oxidase B
|
Dopamine is preferred substrate for metabolism.
|
|
Monoamine oxidase B INHIBITORS used for
|
Parkinson's.
|
|
By interfering with synthesis and inactivation,
|
Reduced specificity.
|
|
Transmitter-receptor interaction provides
|
Greatest specificity.(existence of receptor subtypes-D1/D2 receptors)
|
|
For greater specificity,we target
|
Receptor subtype.
|
|
Receptor types
|
-Ligand gated
-G-protein coupled -Tyrosine kinase -Cytoplasmic/nuclear |
|
Ligand gated receptors
|
-Use Ions/Ca2+ conc. change
-Milliseconds |
|
G-protein coupled receptors
|
-Muscarinic
-Alpha & Beta adrenoceptors -Second messengers -Ca2+ release -Protein phosphorylation -Seconds |
|
Tyrosine kinase receptors
|
-Second messengers
-Minutes |
|
Cytoplasmic/nuclear receptors
|
-mRNA synthesis
-pz synthesis -Hours |
|
Pre synaptic input to neurones :-
|
-nerve terminals
-Modulation of release(autoreceptors such as NT/heteroreceptors-1 nerve regulating release of another one) |
|
Post-synaptic input to neurones
|
-Cell body/dendrites
-AP generation. |
|
Epilepsy
|
Excessive discharge of motor nerves
|
|
Rx to treat epilepsy
|
-Reduce excitatory input
-Enhance inhibitory input |
|
GABA
|
inhibitory
|
|
Glutamate
|
Excitatory
|
|
Phenytoin
|
Limits excitatory nerve activation-stops firing of AP
|